Non-O1 and non-O139 Vibrio cholerae Septicemia and Cellulitis: a Case Report.


Journal

The new microbiologica
ISSN: 1121-7138
Titre abrégé: New Microbiol
Pays: Italy
ID NLM: 9516291

Informations de publication

Date de publication:
Jul 2024
Historique:
received: 18 07 2024
accepted: 18 07 2024
medline: 18 7 2024
pubmed: 18 7 2024
entrez: 18 7 2024
Statut: ppublish

Résumé

Non-O1 and non-O139 Vibrio cholerae (NOVC) are serogroups that do not produce cholera toxin and are not responsible for epidemics. Even though rarely encountered in clinical practice, they can cause a spectrum of different conditions ranging from mild gastrointestinal syndrome to extraintestinal diseases, of which bacteremia and wound infections are the most severe. Risk factors for severe disease are cirrhosis, neoplasms, and diabetes mellitus. The mortality rate of NOVC bacteremia in hospitalized patients ranges from 24 to 61.5%. Incidence of NOVC infections is still rare, and consensus recommendations on treatment are not available. We report a case of NOVC bacteremia associated with severe cellulitis in an immunocompetent 75-year-old man who had eaten raw seafood in a location by the northern Adriatic Sea (Italy). Twenty-four hours after intake, he developed a high fever and vomiting. Afterwards, he started noticing the appearance of cellulitis in his right leg, which worsened in a matter of hours. The patient had a history of compensated type 2 diabetes mellitus. NOVC was isolated from both blood cultures and the leg ulcer. The non-O1, non-O139 serogroup was confirmed, and the detection of the cholera toxin gene was negative. Both tests were performed by the Reference National Laboratory of Istituto Superiore di Sanità (ISS). Multiple antimicrobial regimens were administered, with complete recovery. In conclusion, considering the severity of NOVC-associated manifestations, it is of pivotal importance to reach etiological diagnosis for a target antimicrobial therapy and to consider V. cholerae infection in the differential diagnosis in the presence of risk factors and potential exposure.

Identifiants

pubmed: 39023531

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

190-193

Auteurs

Marcella Negri (M)

Vita-Salute San Raffaele University, Milan, Italy.

Floriana Gona (F)

Microbiology and Virology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Chiara Tassan Din (C)

Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Angelo Roberto Raccagni (AR)

Vita-Salute San Raffaele University, Milan, Italy.

Costanza Bertoni (C)

Vita-Salute San Raffaele University, Milan, Italy.

Matteo Moro (M)

Infection Control, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Laura Villa (L)

Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.

Massimo Locatelli (M)

Microbiology and Virology Department, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Antonella Castagna (A)

Vita-Salute San Raffaele University, Milan, Italy.
Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Monica Guffanti (M)

Infectious Diseases Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH